Long-term Stability of a Compounded Suspension of Torsemide (5 mg/mL) for Oral Administration.

Darcy B AdinP R JohnsonC H KimT NguyenbaS Rosen

Published in: Journal of veterinary internal medicine (2017)

Increasing torsemide use warrants availability of a validated and stable compounded formulation. Our results support the assignment of a 90-day BUD for torsemide 5 mg/mL suspension for oral administration compounded in OraPlus:Sweet 1:1 buffered to a pH of 8.3.

Keyphrases

drug delivery